Conor Fearon

Dr. Conor Fearon


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2021 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
CFConor Fearon
Conor Fearon
ALAnthony E. Lang
Anthony E. Lang
AEAlberto J. Espay
Alberto J. Espay

11 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SMSenan Maher
Senan Maher
EDEoghan Donlon
Eoghan Donlon
GMGerard Mullane
Gerard Mullane
RWRichard A Walsh
Richard A Walsh
TLTim Lynch
Tim Lynch
CFConor Fearon
Conor Fearon
Apathy is a prevalent and highly debilitating non-motor symptom of Parkinson’s disease (PD) that is often overlooked in clinical practice due to its subtle nature. This review aims to provide a comprehensive overview of the current evidence for the treatment of apathy in PD, highlighting recent advancements and emerging therapeutic avenues. In this review, we analyse a diverse array of treatment strategies for apathy in PD, including pharmacological interventions, non-pharmacological approaches, and emerging neuromodulation techniques. We evaluate the efficacy, safety, and limitations of established pharmacotherapies, such as dopaminergic agents, antidepressants, and cognitive enhancers. Additionally, we examine the promising role of non-pharmacological interventions, encompassing psychotherapies and behavioural interventions, in ameliorating apathetic symptoms. Furthermore, this review explores the effects of neuromodulation techniques on apathy, including the modulation of apathy via deep brain stimulation and emerging data on the potential influence of transcranial magnetic stimulation (TMS) on apathy in PD. Ultimately, a deeper understanding of effective treatment strategies for apathy has the potential to significantly improve the quality of life and overall well-being of individuals living with PD.

27 May 2021 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
CFConor Fearon
Conor Fearon
DMDavid J. Mikulis
David J. Mikulis
ALAnthony E. Lang
Anthony E. Lang

8 May 2023 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
DLDaniel G. Di Luca
Daniel G. Di Luca
GGGabriela S. Gilmour
Gabriela S. Gilmour
CFConor Fearon
Conor Fearon
ESEmily Swinkin
Emily Swinkin
EFEliza Freitas
Eliza Freitas
Tiago A. MestreTiago A. Mestre
Tiago A. Mestre

28 April 2022 in Movement Disorders Clinical Practice
Verified
Journal Article
Open access
JBJulien F. Bally
Julien F. Bally
DKDrew S. Kern
Drew S. Kern
CFConor Fearon
Conor Fearon
SCSarah Camargos
Sarah Camargos
FSFrancisco Pereira da Silva‐Junior
Francisco Pereira da Silva‐Junior
ALAnthony E. Lang
Anthony E. Lang
Background: DYT‐TUBB4A, formerly known as DYT4, has not been comprehensively described as only one large family and three individual cases have been published. We have recently described an in depth genetic and protein structural analysis of eleven additional cases from four families with four new pathogenic variants. We aim to report on the phenomenology of these cases suffering from DYT‐TUBB4A and to perform a comprehensive review of the clinical presentation and treatment responses of all DYT‐TUBB4A cases reported in the literature.Cases and Literature Review: The clinical picture was typically characterized by laryngeal dystonia (more than three quarters of all cases), associated with cervical dystonia, upper limb dystonia and frequent generalization. Extension of the dystonia to the lower limbs, creating the famous “hobby horse” gait, was present in more than 20% of cases (in only one of ours). Globus pallidus pars interna (GPi) deep brain stimulation (DBS), performed in 4 cases, led to a good improvement with greatest benefit in motoric and less benefit in laryngeal symptoms. Medical treatment was generally rather poorly effective, except some benefit from propranolol, tetrabenazine and alcohol intake.Conclusion: Laryngeal involvement is a hallmark of DYT‐TUBB4A. Symptomatic treatment with GPi‐DBS led to the greatest benefit in motoric symptoms. Nevertheless, TUBB4A mutations remain an exceedingly rare cause of laryngeal or other isolated dystonia and regular screening of TUBB4A mutations for isolated dystonias has a very low yield.

29 August 2019 in Practical Neurology
Verified
Journal Article
Closed access
PDF file
CFConor Fearon
Conor Fearon
RLRoisin Lonergan
Roisin Lonergan
DFDamien Ferguson
Damien Ferguson
SBSusan Byrne
Susan Byrne
DBDavid Bradley
David Bradley
JRJanice Redmond
Janice Redmond
Friedreich’s ataxia is classically considered a disease with onset in the first or second decade. However, late-onset (age of onset 25–39 years) and very-late-onset (age of onset >40 years) forms do occur rarely. Misdiagnosis is common, particularly because the later onset forms of Friedreich’s ataxia commonly do not show characteristic features of the disorder (areflexia, dysarthria, sensory neuropathy, extensor plantars, amyotrophy, cardiac involvement, diabetes mellitus, scoliosis). Also, there may be atypical features such as spasticity, brisk reflexes and laryngeal dystonia. We present the clinical, imaging and genetic findings of a kindred with very-late-onset Friedreich’s ataxia and discuss the pitfalls and risk of misdiagnosis.